| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.3M | -10.8% | -3.4% |
| R&D Expense | $4.8M | +0.6% | +36.2% |
| SG&A Expense | $5.9M | -2.8% | -3.4% |
| Operating Income | -$3.2M | -65.2% | -66.2% |
| Pre-tax Income | -$2.9M | -74.4% | -100.3% |
| Income Tax | $0 | — | — |
| Net Income | -$3.1M | -67.6% | -91.1% |
| EPS (Basic) | -$0.09 | -50.0% | -80.0% |
| EPS (Diluted) | -$0.09 | -50.0% | -80.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.9M | -3.0% | — |
| Current Assets | $34.6M | -0.7% | — |
| Total Assets | $73.7M | -2.6% | — |
| Current Liabilities | $11.3M | +17.4% | — |
| Total Liabilities | $15.2M | +10.9% | — |
| Stockholders' Equity | $21.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.4M | — | — |
| Investing Cash Flow | -$5.3M | — | — |
| Financing Cash Flow | $694K | — | — |
| -14.5% |
| -54.8% |